Liz is right
for a individual patient 90% cure rate does not mean a damn thing if you happen to belong to the 10%.
As far as individual treatment plans go.. if you take a step back you see that what is currently done it is fairly standard, despite all the cool ideas/hype.... just look at our signature lines. Eventually we will be there that genetic test will help to optimize treatment. For example could/should you use Erbitux etc.
For the sake of argument lets assume we can already do these tests.. where do all the new individualized drugs come from? I concede that some of the drugs may be old stuff.... but there just are not that many.
The quoted paper (OCF) is perhaps not that basic. This reflects how intricate the issue really is. There are many things going on..... and even if you understand all or most of this (and there is more) it will not really help you because the treatment variations are fairly minor.

M